- Home
- KYMR vs MNDY Comparison
KYMR vs MNDY Comparison
Compare KYMR & MNDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KYMR | MNDY |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 7.4B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | KYMR | MNDY |
|---|---|---|
| Price | $87.70 | $70.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 24 | 25 |
| Target Price | $105.96 | ★ $174.92 |
| AVG Volume (30 Days) | 707.0K | ★ 3.7M |
| Earning Date | 04-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $47,072,000.00 | N/A |
| Revenue This Year | $19.43 | $21.02 |
| Revenue Next Year | N/A | $17.04 |
| P/E Ratio | ★ N/A | $34.38 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.45 | $68.68 |
| 52 Week High | $103.00 | $316.98 |
Technical Indicators
Market Signals| Indicator | KYMR | MNDY |
|---|---|---|
| Relative Strength Index (RSI) | 68.85 | 19.82 |
| Support Level | $77.78 | $68.68 |
| Resistance Level | $103.00 | $151.00 |
| Average True Range (ATR) | 3.97 | 6.34 |
| MACD | 1.00 | -0.29 |
| Stochastic Oscillator | 86.86 | 3.04 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About MNDY monday.com Ltd.
Monday.com is a work management platform allowing for increased collaboration and visibility across an organization. Delivered via a SaaS-based model, users can track progress across marketing and development initiatives, create and automate workflows, and manage IT approvals. Revenue is generated on a per-seat basis across several pricing tiers. As of fiscal 2024, the company had over 245,000 customers.